A proof-of concept study: Investigating the impact of COMT genotype and proline on negative symptoms in Alzheimer's disease.
Clelland, J. D.; Cure, H. W.; Canizares, A. M.; Anderson, J. H.; Rawal, B.; Wong, S. A.; Kerner, N.; Huey, E. D.; Honig, L. S.; Devanand, D. P.; Clelland, C.
Show abstract
Previous studies have reported that levels of fasting plasma proline and catechol-O-methyltransferase (COMT) Val158Met genotype influence negative symptoms in patients with severe psychiatric illness and those at-risk for psychosis. Parallel negative neuropsychiatric symptoms are also a core feature of Alzheimers disease (AD). In this proof-of-concept cross-sectional study of dementia patients, we explored the relationship between COMT and proline on negative neuropsychiatric symptoms. The proline x COMT interaction significantly predicted symptoms as assessed via the negative items of the Positive and Negative Symptom Scale (n=50, interaction coefficient=0.025, p=0.031): Higher proline was beneficial for both Val/Val and Val/Met dementia patients, but detrimental to Met/Met patients. That high proline also has opposing effects on negative symptoms by COMT genotype in patients with dementia, further supports the development of therapeutics to specifically target the interaction pathway across neuropsychiatric disorders.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease 94%
- African Ancestry GWAS of Dementia in a Large Military Cohort Identifies Significant Risk Loci 94%
- Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer’s disease 94%
Similar papers in this journal
- Natural Anti-NMDAR1 Autoantibodies Associate with Slowed Decline of Cognitive Functions in Alzheimer's Diseases 92%
- Polygenic resilience scores capture protective genetic effects for Alzheimer’s disease 92%
- The social dimension of apathy: Evidence for a distinct domain from 11,243 individuals across health and neurocognitive disorders 91%
Similar papers in this journal
Similar papers in this journal
- TREM2 Risk Variants with Alzheimer’s Disease Differ in Rate of Cognitive Decline 93%
- Medial temporal lobe atrophy patterns in early- versus late-onset amnestic Alzheimer's disease 93%
- Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.